Mars Drops £161M Into UK Factory While Indie Shelf Space Shrinks

Mars just committed £161 million to modernize its Melton Mowbray factory, a substantial manufacturing investment in a UK pet food facility.

The repeated move you're watching

Mars is locking £161 million into a site that already supplies 95% of its output to British households.

Mars has been in Melton Mowbray for 75 years, it's the birthplace of Whiskas and Pedigree. The modernization runs through 2031 and will make the site Mars's primary pouched pet food factory in the UK. New lines will support recyclable mono-polypropylene packaging and support the company's goal to reach net zero by 2050. The company is adding AI-powered cameras to catch quality defects earlier and cut waste. In year one, the investment creates 30+ technical and engineering roles and expands the apprenticeship program to 33 positions.

Sharon Ross, plant manager at Mars Melton Mowbray: "This £161 million investment is a profound vote of confidence in our site, our Associates, and the wider community. By integrating cutting-edge technology and expanding our apprenticeship programme, we are building on our proud heritage, equipping the next generation with future-ready engineering skills, and writing an exciting new chapter for the iconic brands like Whiskas made right here."

What the pattern predicts

Factory capacity is SKU runway. More line capacity means more sub-brands, more flavors, more formats, all competing for facings independents don't have.

The 95% domestic supply figure is the tell. When a grocery chain or regional pet retailer negotiates terms, Mars walks in with a domestic supply chain that just got £161 million more reliable. The indie store trying to make a margin case for a challenger brand is pitching against a manufacturer who locked in years of cost advantage.

If your week runs on calls like this one, subscribe to PetRetailNews.

Factory investment of this scale typically translates to promotional capacity. Mars will spread this spend across volume, and that math tends to fund the trade programs that make legacy brands sticky on shelf.

What would prove us wrong

If Mars uses the new capacity to launch genuinely differentiated product lines that independents can own, limited-run SKUs, regional exclusives, formats grocers won't stock, then this investment opens shelf space rather than closing it. The mono-PP packaging shift could be that wedge if Mars positions it as a specialty play first and rolls it to grocery later.

The other scenario: if consumer demand for premium and novel protein outpaces Mars's ability to reformulate legacy brands fast enough, the capacity advantage doesn't matter. A factory optimized for pouch production in 2031 is only an asset if pouches are still what buyers want.

Factory capacity is SKU runway, and Mars just bought two decades of it.

The thing to watch next

Mars's first product launch out of the upgraded Melton Mowbray lines. If it's a line extension of an existing grocery brand, the pattern holds. If it's a new sub-brand with a specialty-first distribution strategy, the investment changes meaning.

Also watch how Mars reps frame the sustainability angle when they pitch the mono-PP packaging. If they're positioning it as a retailer differentiator, "stock this because your customers care and Tesco doesn't have it yet", that's a signal Mars sees independents as a launch channel, not just a maintenance account. If they're pitching it as cost-of-goods parity with the old packaging, it's a defensive play and the competitive squeeze continues.

The £161 million is already spent. What it buys depends on what Mars does with the capacity once the lines are running.

← Back to the Newsdesk